About APEN

San Diego-basedLpath, Inc.(LPTN) is the category leader in lipid-targeted therapeutics. The company's ImmuneY2 drug-discovery engine has the unique ability to generate therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease. The company has developed four drug candidates, has advanced the first two to mid-stage trials and built evidence to support its approach of targeting bioactive lipids to treat a wide range of diseases.
Primary Exchange: NASDAQ
SIC Orthopedic, Prosthetic & Surgical Appliances & Supplies
NAICS Surgical and Medical Instrument Manufacturing

APEN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 265 265
IWC iShares Microcap ETF 916.2 M 9.16246E+08 1,452 1452 0.01% 0.0001 76 K 75587

Wait, Before You Leave...